| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 45 | 2025 | 1027 | 4.870 |
Why?
|
| Stress, Physiological | 9 | 2018 | 272 | 2.170 |
Why?
|
| Mutagenesis | 18 | 2023 | 357 | 2.010 |
Why?
|
| DNA Repair | 24 | 2019 | 632 | 1.940 |
Why?
|
| Escherichia coli Proteins | 18 | 2023 | 316 | 1.740 |
Why?
|
| Perciformes | 4 | 2017 | 9 | 1.500 |
Why?
|
| DNA Damage | 14 | 2025 | 546 | 1.490 |
Why?
|
| Recombination, Genetic | 20 | 2019 | 451 | 1.470 |
Why?
|
| DNA Replication | 12 | 2025 | 364 | 1.190 |
Why?
|
| Models, Genetic | 17 | 2019 | 789 | 1.070 |
Why?
|
| Genomic Instability | 8 | 2024 | 245 | 1.040 |
Why?
|
| Gene Amplification | 7 | 2012 | 247 | 1.030 |
Why?
|
| DNA Breaks, Double-Stranded | 14 | 2025 | 141 | 1.010 |
Why?
|
| DNA Copy Number Variations | 9 | 2022 | 1019 | 0.960 |
Why?
|
| Lac Operon | 11 | 2011 | 96 | 0.960 |
Why?
|
| Phylogeny | 4 | 2017 | 785 | 0.950 |
Why?
|
| Mutation | 27 | 2025 | 6304 | 0.940 |
Why?
|
| Chromosomes, Bacterial | 6 | 2015 | 65 | 0.940 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2025 | 288 | 0.720 |
Why?
|
| Maternal Health Services | 2 | 2018 | 43 | 0.710 |
Why?
|
| Point Mutation | 8 | 2014 | 361 | 0.680 |
Why?
|
| Adaptation, Physiological | 5 | 2004 | 289 | 0.670 |
Why?
|
| Evolution, Molecular | 11 | 2012 | 710 | 0.650 |
Why?
|
| Adaptation, Biological | 5 | 2007 | 36 | 0.640 |
Why?
|
| Sigma Factor | 5 | 2019 | 35 | 0.620 |
Why?
|
| Gene Dosage | 4 | 2011 | 458 | 0.620 |
Why?
|
| Clinical Governance | 1 | 2018 | 2 | 0.610 |
Why?
|
| Reproductive Health Services | 1 | 2018 | 19 | 0.600 |
Why?
|
| Bacterial Proteins | 10 | 2019 | 934 | 0.600 |
Why?
|
| Fresh Water | 1 | 2017 | 21 | 0.550 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2019 | 93 | 0.540 |
Why?
|
| Gene Rearrangement | 7 | 2019 | 331 | 0.540 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 2013 | 16 | 0.530 |
Why?
|
| Biological Evolution | 3 | 2011 | 256 | 0.520 |
Why?
|
| RNA | 2 | 2023 | 606 | 0.470 |
Why?
|
| DNA Polymerase beta | 3 | 2010 | 15 | 0.470 |
Why?
|
| Chromosome Aberrations | 3 | 2014 | 626 | 0.470 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2025 | 440 | 0.450 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2023 | 173 | 0.440 |
Why?
|
| DNA Breaks, Single-Stranded | 2 | 2016 | 20 | 0.440 |
Why?
|
| DNA Polymerase II | 2 | 2010 | 21 | 0.420 |
Why?
|
| DNA, Bacterial | 9 | 2016 | 500 | 0.410 |
Why?
|
| Chromosomes, Fungal | 2 | 2012 | 49 | 0.410 |
Why?
|
| Selection, Genetic | 4 | 2012 | 169 | 0.410 |
Why?
|
| DNA | 9 | 2023 | 1680 | 0.400 |
Why?
|
| Chromosomal Instability | 2 | 2019 | 63 | 0.400 |
Why?
|
| DNA, Mitochondrial | 3 | 2024 | 242 | 0.390 |
Why?
|
| Genetic Variation | 4 | 2017 | 1619 | 0.380 |
Why?
|
| DNA Replication Timing | 1 | 2011 | 11 | 0.380 |
Why?
|
| Clonal Evolution | 1 | 2011 | 49 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 5 | 2023 | 2573 | 0.360 |
Why?
|
| DNA-Binding Proteins | 7 | 2022 | 2174 | 0.360 |
Why?
|
| Mutagenesis, Insertional | 3 | 2025 | 157 | 0.350 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 592 | 0.330 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 277 | 0.320 |
Why?
|
| Sequence Homology | 1 | 2009 | 63 | 0.310 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 533 | 0.290 |
Why?
|
| Chromatin | 1 | 2011 | 615 | 0.290 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 707 | 0.280 |
Why?
|
| Social Responsibility | 2 | 2018 | 83 | 0.280 |
Why?
|
| Oxidative Stress | 4 | 2007 | 876 | 0.270 |
Why?
|
| Neoplasms | 5 | 2021 | 3034 | 0.260 |
Why?
|
| Crossing Over, Genetic | 3 | 2011 | 54 | 0.240 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 3979 | 0.240 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2019 | 384 | 0.240 |
Why?
|
| Transcription, Genetic | 3 | 2025 | 1761 | 0.240 |
Why?
|
| DNA End-Joining Repair | 4 | 2025 | 38 | 0.230 |
Why?
|
| Transcription Termination, Genetic | 1 | 2025 | 13 | 0.230 |
Why?
|
| Replication Protein A | 1 | 2025 | 10 | 0.230 |
Why?
|
| Retroelements | 1 | 2024 | 41 | 0.230 |
Why?
|
| Heat-Shock Response | 1 | 2004 | 36 | 0.220 |
Why?
|
| Bayes Theorem | 3 | 2017 | 316 | 0.220 |
Why?
|
| Base Sequence | 9 | 2015 | 3177 | 0.220 |
Why?
|
| Drug Resistance | 1 | 2004 | 264 | 0.210 |
Why?
|
| Drug Resistance, Microbial | 4 | 2023 | 198 | 0.210 |
Why?
|
| Cell Nucleus | 3 | 2024 | 689 | 0.210 |
Why?
|
| DNA, Cruciform | 3 | 2021 | 18 | 0.200 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 245 | 0.200 |
Why?
|
| Exodeoxyribonucleases | 5 | 2025 | 52 | 0.180 |
Why?
|
| Animals | 13 | 2023 | 36527 | 0.180 |
Why?
|
| Chromosome Fragility | 1 | 2021 | 13 | 0.180 |
Why?
|
| Viral Proteins | 2 | 2013 | 360 | 0.180 |
Why?
|
| Genome | 1 | 2004 | 527 | 0.180 |
Why?
|
| Bacteriophage mu | 2 | 2018 | 12 | 0.180 |
Why?
|
| Thymine | 2 | 2011 | 15 | 0.170 |
Why?
|
| Chromosomes | 1 | 2000 | 164 | 0.170 |
Why?
|
| Frameshift Mutation | 4 | 2013 | 199 | 0.170 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2022 | 577 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2019 | 374 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2022 | 419 | 0.160 |
Why?
|
| DNA, Single-Stranded | 2 | 2025 | 76 | 0.160 |
Why?
|
| Genome, Human | 4 | 2019 | 1342 | 0.150 |
Why?
|
| DNA Polymerase III | 3 | 2025 | 28 | 0.150 |
Why?
|
| Health Behavior | 1 | 2022 | 404 | 0.150 |
Why?
|
| Rec A Recombinases | 3 | 2010 | 26 | 0.150 |
Why?
|
| Family Planning Services | 1 | 2018 | 40 | 0.150 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2018 | 39 | 0.150 |
Why?
|
| DNA, Fungal | 2 | 1996 | 78 | 0.150 |
Why?
|
| House Calls | 1 | 2018 | 38 | 0.150 |
Why?
|
| Phylogeography | 2 | 2015 | 20 | 0.150 |
Why?
|
| DNA Polymerase I | 2 | 2010 | 10 | 0.140 |
Why?
|
| Humans | 27 | 2025 | 134037 | 0.140 |
Why?
|
| Community Health Workers | 1 | 2018 | 76 | 0.140 |
Why?
|
| RecQ Helicases | 2 | 2016 | 64 | 0.140 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2017 | 5 | 0.140 |
Why?
|
| Phenotype | 6 | 2015 | 4554 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2010 | 4928 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2018 | 440 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 271 | 0.130 |
Why?
|
| Genomics | 3 | 2015 | 1669 | 0.130 |
Why?
|
| Calibration | 1 | 2017 | 100 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 5 | 2019 | 1831 | 0.130 |
Why?
|
| Genome, Bacterial | 2 | 2015 | 212 | 0.130 |
Why?
|
| Reproductive Health | 1 | 2017 | 48 | 0.130 |
Why?
|
| Cell Division | 4 | 2019 | 774 | 0.120 |
Why?
|
| DNA Helicases | 3 | 2013 | 252 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 266 | 0.120 |
Why?
|
| Gene Library | 1 | 2015 | 225 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 486 | 0.120 |
Why?
|
| Program Evaluation | 1 | 2017 | 457 | 0.110 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 135 | 0.110 |
Why?
|
| Alleles | 5 | 2012 | 1709 | 0.110 |
Why?
|
| Uniparental Disomy | 1 | 2015 | 50 | 0.110 |
Why?
|
| Homologous Recombination | 2 | 2012 | 100 | 0.110 |
Why?
|
| Genes, Bacterial | 2 | 2006 | 218 | 0.110 |
Why?
|
| Models, Biological | 4 | 2010 | 1537 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 582 | 0.110 |
Why?
|
| Exodeoxyribonuclease V | 3 | 2003 | 23 | 0.110 |
Why?
|
| Likelihood Functions | 2 | 2011 | 122 | 0.110 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2025 | 120 | 0.110 |
Why?
|
| DNA Breaks | 1 | 2013 | 26 | 0.110 |
Why?
|
| Health Personnel | 1 | 2018 | 541 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2013 | 74 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2022 | 2729 | 0.100 |
Why?
|
| Serine Endopeptidases | 3 | 2010 | 204 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2013 | 51 | 0.100 |
Why?
|
| Lactose | 2 | 2004 | 56 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 3 | 2005 | 214 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 680 | 0.100 |
Why?
|
| Fungi | 1 | 1992 | 75 | 0.100 |
Why?
|
| Base Pair Mismatch | 3 | 2001 | 22 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2011 | 373 | 0.090 |
Why?
|
| Chromosome Pairing | 1 | 2011 | 7 | 0.090 |
Why?
|
| Chromosome Inversion | 1 | 2011 | 76 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 168 | 0.090 |
Why?
|
| Ciprofloxacin | 2 | 2023 | 68 | 0.090 |
Why?
|
| Time Factors | 2 | 2017 | 6604 | 0.090 |
Why?
|
| Ecosystem | 1 | 2011 | 110 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 806 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 398 | 0.080 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2010 | 23 | 0.080 |
Why?
|
| Meiosis | 3 | 2024 | 117 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2010 | 43 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 678 | 0.080 |
Why?
|
| Gene Duplication | 1 | 2011 | 371 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2019 | 2934 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 632 | 0.080 |
Why?
|
| Yeasts | 1 | 2009 | 43 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2013 | 397 | 0.080 |
Why?
|
| Mutagenicity Tests | 1 | 2008 | 35 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 402 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 566 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 787 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 2 | 2024 | 51 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1071 | 0.070 |
Why?
|
| Fanconi Anemia Complementation Group G Protein | 1 | 2006 | 2 | 0.070 |
Why?
|
| Peroxidases | 1 | 2006 | 28 | 0.070 |
Why?
|
| Fanconi Anemia | 1 | 2006 | 45 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 734 | 0.060 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 2 | 2003 | 9 | 0.060 |
Why?
|
| MutL Proteins | 2 | 2003 | 19 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 295 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2011 | 810 | 0.060 |
Why?
|
| Flap Endonucleases | 1 | 2025 | 4 | 0.060 |
Why?
|
| Helicobacter pylori | 1 | 2014 | 1335 | 0.060 |
Why?
|
| Templates, Genetic | 1 | 2025 | 97 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 2014 | 1278 | 0.060 |
Why?
|
| Chromosome Duplication | 2 | 2019 | 148 | 0.060 |
Why?
|
| Smith-Magenis Syndrome | 2 | 2019 | 105 | 0.060 |
Why?
|
| Kinetics | 2 | 2004 | 1356 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2004 | 194 | 0.060 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 51 | 0.060 |
Why?
|
| Young Adult | 1 | 2018 | 9912 | 0.050 |
Why?
|
| Plasmids | 3 | 2009 | 529 | 0.050 |
Why?
|
| Geologic Sediments | 1 | 2003 | 7 | 0.050 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 315 | 0.050 |
Why?
|
| Air Microbiology | 1 | 2003 | 12 | 0.050 |
Why?
|
| Guanosine Tetraphosphate | 1 | 2023 | 6 | 0.050 |
Why?
|
| Water Microbiology | 1 | 2003 | 31 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 65 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 95 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 91 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 840 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1870 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 793 | 0.050 |
Why?
|
| Mitochondria | 1 | 2006 | 756 | 0.040 |
Why?
|
| Genes, Fungal | 2 | 2008 | 64 | 0.040 |
Why?
|
| Salmonella | 1 | 2000 | 29 | 0.040 |
Why?
|
| Genotype | 3 | 2015 | 2806 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 221 | 0.040 |
Why?
|
| Middle Aged | 2 | 2018 | 29394 | 0.040 |
Why?
|
| Bacteria | 1 | 2004 | 538 | 0.040 |
Why?
|
| Adolescent | 1 | 2018 | 20581 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2003 | 709 | 0.040 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 976 | 0.040 |
Why?
|
| Female | 4 | 2022 | 71822 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 82 | 0.040 |
Why?
|
| Phleomycins | 1 | 2018 | 6 | 0.040 |
Why?
|
| Family | 1 | 2022 | 589 | 0.040 |
Why?
|
| Exonucleases | 1 | 2018 | 25 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 94 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2013 | 837 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 93 | 0.040 |
Why?
|
| Adult | 1 | 2018 | 31959 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 187 | 0.030 |
Why?
|
| Government Programs | 1 | 2017 | 12 | 0.030 |
Why?
|
| Rural Health | 1 | 2017 | 51 | 0.030 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 32 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1998 | 138 | 0.030 |
Why?
|
| Pregnancy | 2 | 2022 | 7568 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2013 | 538 | 0.030 |
Why?
|
| Bacteriophage P1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2015 | 7 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 448 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 139 | 0.030 |
Why?
|
| Genes | 1 | 1976 | 450 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 320 | 0.030 |
Why?
|
| Malawi | 1 | 2017 | 423 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 47 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 1627 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 289 | 0.030 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 31 | 0.030 |
Why?
|
| Ku Autoantigen | 1 | 2013 | 22 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2013 | 15 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2014 | 500 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2022 | 3732 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 717 | 0.020 |
Why?
|
| Infant | 2 | 2022 | 13182 | 0.020 |
Why?
|
| Fish Proteins | 1 | 2011 | 6 | 0.020 |
Why?
|
| Caribbean Region | 1 | 2011 | 20 | 0.020 |
Why?
|
| Genetic Speciation | 1 | 2011 | 28 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 137 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 19034 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1993 | 363 | 0.020 |
Why?
|
| Recombinases | 1 | 2011 | 26 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 93 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 167 | 0.020 |
Why?
|
| Head | 1 | 2011 | 113 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 176 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 197 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 633 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 67 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 189 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 89 | 0.020 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2011 | 312 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 1988 | 32 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 102 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1736 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 300 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2008 | 146 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2012 | 453 | 0.020 |
Why?
|
| Proteins | 1 | 2013 | 1098 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2007 | 27 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 839 | 0.020 |
Why?
|
| Child | 2 | 2022 | 25818 | 0.020 |
Why?
|
| Peroxiredoxin III | 1 | 2006 | 2 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2006 | 10 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 69 | 0.020 |
Why?
|
| Mitomycin | 1 | 2006 | 52 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1140 | 0.020 |
Why?
|
| Peroxidase | 1 | 2006 | 72 | 0.020 |
Why?
|
| Calpain | 1 | 2006 | 42 | 0.020 |
Why?
|
| COS Cells | 1 | 2006 | 284 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 206 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2008 | 500 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1432 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 913 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 131 | 0.020 |
Why?
|
| DNA, Catenated | 1 | 2005 | 3 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 434 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 150 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 135 | 0.020 |
Why?
|
| DNA, Superhelical | 1 | 2005 | 21 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 469 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2006 | 442 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 330 | 0.010 |
Why?
|
| F Factor | 1 | 2004 | 3 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 296 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2664 | 0.010 |
Why?
|
| Male | 3 | 2017 | 66024 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8600 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 922 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 5206 | 0.010 |
Why?
|
| Sildenafil Citrate | 1 | 2001 | 57 | 0.010 |
Why?
|
| Sulfones | 1 | 2001 | 74 | 0.010 |
Why?
|
| Purines | 1 | 2001 | 119 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 208 | 0.010 |
Why?
|
| Interphase | 1 | 1999 | 42 | 0.010 |
Why?
|
| Piperazines | 1 | 2001 | 257 | 0.010 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1998 | 237 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2001 | 932 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 21750 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1976 | 195 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 14819 | 0.010 |
Why?
|